| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 0.0005 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |